{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T22:48:10Z","timestamp":1752360490584,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T00:00:00Z","timestamp":1723507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-162","2022-PUMCH-B-092"],"award-info":[{"award-number":["2022-PUMCH-A-162","2022-PUMCH-B-092"]}]},{"name":"Beijing Municipal Natural Science Foundation","award":["Z210017"],"award-info":[{"award-number":["Z210017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Proteom"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1186\/s12014-024-09503-7","type":"journal-article","created":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T04:02:16Z","timestamp":1723521736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Application of urine proteomics in the diagnosis and treatment effectiveness monitoring of early-stage Mycosis Fungoides"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-5512","authenticated-orcid":false,"given":"Hongbin","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0838-7559","authenticated-orcid":false,"given":"Zhonghui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0923-800X","authenticated-orcid":false,"given":"Shiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6433-9298","authenticated-orcid":false,"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-3545-2387","authenticated-orcid":false,"given":"Jindi","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8925-749X","authenticated-orcid":false,"given":"Lu","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-0675","authenticated-orcid":false,"given":"Yuehua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9998-2862","authenticated-orcid":false,"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,8,13]]},"reference":[{"key":"9503_CR1","doi-asserted-by":"publisher","unstructured":"Larocca C A, Leboeuf NR. Overview of Cutaneous T-Cell Lymphomas [J]. Hematology\/oncology clinics of North America, 2019, 33(4): 669\u2009\u2013\u200986. https:\/\/doi.org\/10.1016\/j.hoc.2019.04.004","DOI":"10.1016\/j.hoc.2019.04.004"},{"issue":"21","key":"9503_CR2","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"BRADFORD P T","year":"2009","unstructured":"Bradford P T, Devesa S S, Anderson W F, et al. Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases [J]. Blood. 2009;113(21):5064\u201373. https:\/\/doi.org\/10.1182\/blood-2008-10-184168.","journal-title":"Blood"},{"key":"9503_CR3","doi-asserted-by":"publisher","unstructured":"Cerroni L. Mycosis fungoides-clinical and histopathologic features, differential diagnosis, and treatment [J]. Seminars in cutaneous medicine and surgery, 2018, 37(1): 2\u201310. https:\/\/doi.org\/10.12788\/j.sder.2018.002","DOI":"10.12788\/j.sder.2018.002"},{"issue":"3","key":"9503_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.clindermatol.2019.01.004","volume":"37","author":"HODAKE AMITAY-LAISH I","year":"2019","unstructured":"Hodak E, Amitay-laish I. Mycosis fungoides: a great imitator [J]. Clin Dermatol. 2019;37(3):255\u201367. https:\/\/doi.org\/10.1016\/j.clindermatol.2019.01.004.","journal-title":"Clin Dermatol"},{"issue":"6","key":"9503_CR5","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1067\/mjd.2002.124696","volume":"47","author":"HS ZACKHEIM","year":"2002","unstructured":"Zackheim HS, Mccalmont T H. Mycosis fungoides: the great imitator [J]. J Am Acad Dermatol. 2002;47(6):914\u20138. https:\/\/doi.org\/10.1067\/mjd.2002.124696.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"9503_CR6","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11864-020-00809-w","volume":"22","author":"H KAMIJO","year":"2021","unstructured":"Kamijo H, Miyagaki T. Mycosis fungoides and s\u00e9zary syndrome: updates and review of current therapy [J]. Curr Treat Options Oncol. 2021;22(2):10. https:\/\/doi.org\/10.1007\/s11864-020-00809-w.","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"9503_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","volume":"55","author":"B ASLAM","year":"2017","unstructured":"Aslam B, Basit M, Nisar MA, et al. Proteomics: technologies and their applications [J]. J Chromatogr Sci. 2017;55(2):182\u201396. https:\/\/doi.org\/10.1093\/chromsci\/bmw167.","journal-title":"J Chromatogr Sci"},{"issue":"5771","key":"9503_CR8","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1126\/science.1124619","volume":"312","author":"B DOMON","year":"2006","unstructured":"Domon B, Aebersold R. Mass spectrometry and protein analysis [J]. Science. 2006;312(5771):212\u20137. https:\/\/doi.org\/10.1126\/science.1124619.","journal-title":"Science"},{"issue":"6","key":"9503_CR9","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/pmic.201000599","volume":"11","author":"N SELEVSEK","year":"2011","unstructured":"Selevsek N, Matondo M, Sanchez carbayo M, et al. Systematic quantification of peptides\/proteins in urine using selected reaction monitoring [J]. Proteomics. 2011;11(6):1135\u201347. https:\/\/doi.org\/10.1002\/pmic.201000599.","journal-title":"Proteomics"},{"issue":"7","key":"9503_CR10","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1007\/s00436-020-06712-5","volume":"119","author":"R MAGNI","year":"2020","unstructured":"Magni R, Luchini A, Liotta L, et al. Proteomic analysis reveals pathogen-derived biomarkers of acute babesiosis in erythrocytes, plasma, and urine of infected hamsters [J]. Parasitol Res. 2020;119(7):2227\u201335. https:\/\/doi.org\/10.1007\/s00436-020-06712-5.","journal-title":"Parasitol Res"},{"issue":"5","key":"9503_CR11","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s11427-011-4162-1","volume":"54","author":"C SHAO","year":"2011","unstructured":"Shao C, Wang Y, Gao Y. Applications of urinary proteomics in biomarker discovery [J]. Sci China Life Sci. 2011;54(5):409\u201317. https:\/\/doi.org\/10.1007\/s11427-011-4162-1.","journal-title":"Sci China Life Sci"},{"key":"9503_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12014-020-09274-x","volume":"17","author":"X FANG","year":"2020","unstructured":"Fang X, Wu H, Lu M, et al. Urinary proteomics of Henoch-Sch\u00f6nlein purpura nephritis in children using liquid chromatography-tandem mass spectrometry [J]. Clin Proteomics. 2020;17:10. https:\/\/doi.org\/10.1186\/s12014-020-09274-x.","journal-title":"Clin Proteomics"},{"issue":"6","key":"9503_CR13","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","volume":"53","author":"M PIMPINELLI N, OLSEN E A, SANTUCCI","year":"2005","unstructured":"Pimpinelli N, Olsen E A, Santucci M, et al. Defining early mycosis fungoides [J]. J Am Acad Dermatol. 2005;53(6):1053\u201363. https:\/\/doi.org\/10.1016\/j.jaad.2005.08.057.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"9503_CR14","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E OLSEN","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, et al. Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) [J]. Blood. 2007;110(6):1713\u201322. https:\/\/doi.org\/10.1182\/blood-2007-03-055749.","journal-title":"Blood"},{"key":"9503_CR15","doi-asserted-by":"publisher","unstructured":"Naryzhny S. Proteomics and its applications in cancers [J]. Int J Mol Sci, 2023, 24(5): 4457. https:\/\/doi.org\/10.3390\/ijms24054457","DOI":"10.3390\/ijms24054457"},{"issue":"8","key":"9503_CR16","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.3390\/biom12081021","volume":"12","author":"SARHADI V K","year":"2022","unstructured":"Sarhadi V K, Armengol G. Molecular biomarkers in cancer [J]. Biomolecules. 2022;12(8):1021. https:\/\/doi.org\/10.3390\/biom12081021.","journal-title":"Biomolecules"},{"issue":"5","key":"9503_CR17","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1002\/mas.20356","volume":"31","author":"MC TAN H T, LEE Y H, CHUNG","year":"2012","unstructured":"Tan H T, Lee Y H, Chung MC. Cancer proteomics [J]. Mass Spectrom Rev. 2012;31(5):583\u2013605. https:\/\/doi.org\/10.1002\/mas.20356.","journal-title":"Mass Spectrom Rev"},{"issue":"11","key":"9503_CR18","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.3390\/cells10113190","volume":"10","author":"J LAI","year":"2021","unstructured":"Lai J, Li J, Gniadecki R, et al. Gene expression profiling of mycosis fungoides in early and tumor stage-a proof-of-concept study using laser capture\/single cell microdissection and nanoString analysis [J] Cells. 2021;10(11):3190. https:\/\/doi.org\/10.3390\/cells10113190.","journal-title":"Anal [J] Cells"},{"issue":"12","key":"9503_CR19","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/exd.12547","volume":"23","author":"E PAPADAVID","year":"2014","unstructured":"Papadavid E, Korkolopoulou P, Levidou G, et al. In situ assessment of PI3K and PTEN alterations in mycosis fungoides: correlation with clinicopathological features [J]. Exp Dermatol. 2014;23(12):931\u20133. https:\/\/doi.org\/10.1111\/exd.12547.","journal-title":"Exp Dermatol"},{"issue":"3","key":"9503_CR20","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jaad.2013.04.027","volume":"69","author":"G LEVIDOU","year":"2013","unstructured":"Levidou G, Siakantaris M, Papadaki T, et al. A comprehensive immunohistochemical approach of AKT\/mTOR pathway and p-STAT3 in mycosis fungoides [J]. J Am Acad Dermatol. 2013;69(3):375\u201384. https:\/\/doi.org\/10.1016\/j.jaad.2013.04.027.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"9503_CR21","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/ijd.15451","volume":"60","author":"LA REND\u00f3N-SERNA N, CORREA-LONDO\u00f1O","year":"2021","unstructured":"Rend\u00f3n-serna N, Correa-londo\u00f1o LA, Vel\u00e1squez-lopera M M, et al. Cell signaling in cutaneous T-cell lymphoma microenvironment: promising targets for molecular-specific treatment [J]. Int J Dermatol. 2021;60(12):1462\u201380. https:\/\/doi.org\/10.1111\/ijd.15451.","journal-title":"Int J Dermatol"},{"issue":"7","key":"9503_CR22","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1080\/10428194.2017.1370548","volume":"59","author":"A SHUKLA","year":"2018","unstructured":"Shukla A, Shukla V, Joshi SS. Regulation of MAPK signaling and implications in chronic lymphocytic leukemia [J]. Leuk Lymphoma. 2018;59(7):1565\u201373. https:\/\/doi.org\/10.1080\/10428194.2017.1370548.","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"9503_CR23","first-page":"580","volume":"26","author":"Y ZHANG","year":"2021","unstructured":"Zhang Y, Zhang J. MiR-223 suppresses proliferation and promotes apoptosis of diffuse large B-Cell lymphoma cells through Lmo2 and MAPK signaling pathway [J]. J BUON. 2021;26(2):580\u20136.","journal-title":"J BUON: Official J Balkan Union Oncol"},{"issue":"5","key":"9503_CR24","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.sjbs.2018.05.010","volume":"25","author":"W WANG","year":"2018","unstructured":"Wang W, Lin P, Yao H, et al. MicroRNA-4728 serves as a suppressor and antagonist of oncogenic MAPK in Burkitt lymphoma [J]. Saudi J Biol Sci. 2018;25(5):982\u20135. https:\/\/doi.org\/10.1016\/j.sjbs.2018.05.010.","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"9503_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3892\/ol.2022.13344","volume":"24","author":"D BAI","year":"2022","unstructured":"Bai D, Zhou Y, Shen F, et al. BPTF activates the MAPK pathway through coexpression with Raf1 to promote proliferation of T-cell lymphoma [J]. Oncol Lett. 2022;24(1):223. https:\/\/doi.org\/10.3892\/ol.2022.13344.","journal-title":"Oncol Lett"},{"issue":"11","key":"9503_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3390\/cancers10110402","volume":"10","author":"S LATOUR","year":"2018","unstructured":"Latour S, Mahouche I, Cherrier F, et al. Calcium independent effect of Orai1 and STIM1 in Non-hodgkin B Cell Lymphoma dissemination [J]. Cancers. 2018;10(11):402. https:\/\/doi.org\/10.3390\/cancers10110402.","journal-title":"Cancers"},{"issue":"14","key":"9503_CR27","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.3390\/cancers13143579","volume":"13","author":"M BEREHAB","year":"2021","unstructured":"Berehab M, Rouas R, Akl H, et al. Apoptotic and non-apoptotic modalities of Thymoquinone-Induced Lymphoma Cell death: highlight of the role of cytosolic calcium and necroptosis [J]. Cancers. 2021;13(14):3579. https:\/\/doi.org\/10.3390\/cancers13143579.","journal-title":"Cancers"},{"issue":"3","key":"9503_CR28","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1124\/mol.118.114405","volume":"95","author":"M MATSUI","year":"2019","unstructured":"Matsui M, Kajikuri J, Kito H, et al. Inhibition of Interleukin 10 transcription through the SMAD2\/3 signaling pathway by ca(2+)-Activated K(+) Channel K(ca)3.1 activation in human T-Cell lymphoma HuT-78 cells [J]. Mol Pharmacol. 2019;95(3):294\u2013302. https:\/\/doi.org\/10.1124\/mol.118.114405.","journal-title":"Mol Pharmacol"},{"issue":"2","key":"9503_CR29","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4103\/0378-6323.77456","volume":"77","author":"U KHOPKAR","year":"2011","unstructured":"Khopkar U, Doshi B R, Dongre A M, et al. A study of clinicopathologic profile of 15 cases of hypopigmented mycosis fungoides [J]. Indian J Dermatol Venereol Leprol. 2011;77(2):167\u201373. https:\/\/doi.org\/10.4103\/0378-6323.77456.","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5","key":"9503_CR30","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1046\/j.1525-1470.2000.017005403.x","volume":"17","author":"AM NEUHAUS I M, RAMOS-CARO F A, HASSAN","year":"2000","unstructured":"Neuhaus I M, Ramos-Caro F A, Hassanein AM. Hypopigmented mycosis fungoides in childhood and adolescence [J]. Pediatr Dermatol. 2000;17(5):403\u20136. https:\/\/doi.org\/10.1046\/j.1525-1470.2000.017005403.x.","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"9503_CR31","doi-asserted-by":"publisher","first-page":"123","DOI":"10.2174\/1871529x11313020005","volume":"13","author":"D ZHENG","year":"2013","unstructured":"Zheng D, Chen H, Davids J, et al. Serpins for diagnosis and therapy in cancer [J]. Cardiovasc Hematol Disord Drug Targets. 2013;13(2):123\u201332. https:\/\/doi.org\/10.2174\/1871529x11313020005.","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"9503_CR32","doi-asserted-by":"publisher","unstructured":"Bodenstine T M, Seftor R E, Khalkhali-Ellis Z et al. Maspin: molecular mechanisms and therapeutic implications [J]. Cancer Metastasis Rev. 2012;31(3\u20134): 529\u201351. https:\/\/doi.org\/10.1007\/s10555-012-9361-0.","DOI":"10.1007\/s10555-012-9361-0"},{"issue":"1","key":"9503_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2001-1326-2-8","volume":"2","author":"R BERARDI","year":"2013","unstructured":"Berardi R, Morgese F, Onofri A, et al. Role of maspin in cancer [J]. Clin Translational Med. 2013;2(1):8. https:\/\/doi.org\/10.1186\/2001-1326-2-8.","journal-title":"Clin Translational Med"},{"issue":"1","key":"9503_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.0022-202X.2004.23501.x","volume":"124","author":"LM CARL\u00e9N","year":"2005","unstructured":"Carl\u00e9n LM, S\u00e1nchez F, Bergman A C, et al. Proteome analysis of skin distinguishes acute guttate from chronic plaque psoriasis [J]. J Invest Dermatol. 2005;124(1):63\u20139. https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23501.x.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"9503_CR35","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/jcp.30614","volume":"237","author":"HD BRAHMBHATT","year":"2022","unstructured":"Brahmbhatt HD, Gupta R, Gupta A, et al. Differential regulation of mir-21-5p delays wound healing of melanocyte-deprived vitiligo skin by modulating the expression of tumor-suppressors PDCD4 and maspin [J]. J Cell Physiol. 2022;237(2):1429\u201339. https:\/\/doi.org\/10.1002\/jcp.30614.","journal-title":"J Cell Physiol"},{"issue":"9","key":"9503_CR36","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1002\/ijc.21620","volume":"118","author":"W DIETMAIER","year":"2006","unstructured":"Dietmaier W, Bettstetter M, Wild PJ, et al. Nuclear maspin expression is associated with response to adjuvant 5-fluorouracil based chemotherapy in patients with stage III colon cancer [J]. Int J Cancer. 2006;118(9):2247\u201354. https:\/\/doi.org\/10.1002\/ijc.21620.","journal-title":"Int J Cancer"},{"issue":"9","key":"9503_CR37","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1200\/JCO.2000.18.9.1914","volume":"18","author":"R SABBATINI","year":"2000","unstructured":"Sabbatini R, Federico M, Morselli M, et al. Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy [J]. J Clin Oncol. 2000;18(9):1914\u201320. https:\/\/doi.org\/10.1200\/JCO.2000.18.9.1914.","journal-title":"J Clin Oncology: Official J Am Soc Clin Oncol"},{"issue":"12","key":"9503_CR38","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1038\/sj.bjc.6602630","volume":"92","author":"J RIDDICK A C, SHUKLA C J, PENNINGTON","year":"2005","unstructured":"Riddick A C, Shukla C J, Pennington C J, et al. Identification of degradome components associated with prostate cancer progression by expression analysis of human prostatic tissues [J]. Br J Cancer. 2005;92(12):2171\u201380. https:\/\/doi.org\/10.1038\/sj.bjc.6602630.","journal-title":"Br J Cancer"},{"key":"9503_CR39","doi-asserted-by":"publisher","unstructured":"Machtens S, Serth J, Bokemeyer C et al. Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features [J]. Int J Cancer. 2001;95(5): 337\u201342. https:\/\/doi.org\/10.1002\/1097-0215(20010920)95:5%3C337::aid-ijc1059%3E3.0.co;2-1.","DOI":"10.1002\/1097-0215(20010920)95:5%3C337::aid-ijc1059%3E3.0.co;2-1"},{"issue":"9","key":"9503_CR40","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.jtho.2018.04.030","volume":"13","author":"CODONY-SERVAT J","year":"2018","unstructured":"Codony-servat J, Garc\u00eda-roman S, Molina-vila M, et al. Anti-epidermal growth factor vaccine antibodies enhance the efficacy of tyrosine kinase inhibitors and delay the emergence of resistance in EGFR Mutant lung cancer cells [J]. J Thorac Oncol. 2018;13(9):1324\u201337. https:\/\/doi.org\/10.1016\/j.jtho.2018.04.030.","journal-title":"J Thorac Oncology: Official Publication Int Association Study Lung Cancer"},{"issue":"suppl1","key":"9503_CR41","doi-asserted-by":"publisher","first-page":"i10","DOI":"10.1093\/annonc\/mdx703","volume":"29","author":"D WESTOVER","year":"2018","unstructured":"Westover D, Zugazagoitia J, Cho B C, et al. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors [J]. Ann Oncol. 2018;29(suppl_1):i10\u20139. https:\/\/doi.org\/10.1093\/annonc\/mdx703.","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol"},{"key":"9503_CR42","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12935-014-0134-4","volume":"14","author":"Q PENG","year":"2014","unstructured":"Peng Q, Li S, Qin X, et al. EGF\u2009+\u200961A\/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis [J]. Cancer Cell Int. 2014;14:134. https:\/\/doi.org\/10.1186\/s12935-014-0134-4.","journal-title":"Cancer Cell Int"},{"key":"9503_CR43","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1186\/s12885-015-1318-6","volume":"15","author":"G JIANG","year":"2015","unstructured":"Jiang G, Yu K, Shao L, et al. Association between epidermal growth factor gene\u2009+\u200961A\/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies [J]. BMC Cancer. 2015;15:314. https:\/\/doi.org\/10.1186\/s12885-015-1318-6.","journal-title":"BMC Cancer"},{"issue":"6","key":"9503_CR44","doi-asserted-by":"publisher","first-page":"BSR20201175","DOI":"10.1042\/BSR20201175","volume":"40","author":"Q ZI-CHEN G, JIN","year":"2020","unstructured":"Zi-chen G, Jin Q, Yi-na Z, et al. Colorectal cancer cells promote osteoclastogenesis and bone destruction through regulating EGF\/ERK\/CCL3 pathway [J]. Biosci Rep. 2020;40(6):BSR20201175. https:\/\/doi.org\/10.1042\/BSR20201175.","journal-title":"Biosci Rep"},{"issue":"10","key":"9503_CR45","doi-asserted-by":"publisher","first-page":"5306","DOI":"10.3390\/ijms22105306","volume":"22","author":"Y SHEN","year":"2021","unstructured":"Shen Y, Lee H J, Zhou R, et al. \u03b4-Catenin participates in EGF\/AKT\/p21(waf) signaling and induces prostate Cancer Cell Proliferation and Invasion [J]. Int J Mol Sci. 2021;22(10):5306. https:\/\/doi.org\/10.3390\/ijms22105306.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"9503_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1046\/j.1365-2133.1999.02703.x","volume":"140","author":"P COURVILLE","year":"1999","unstructured":"Courville P, Wechsler J, Thomine E, et al. Pseudoepitheliomatous hyperplasia in cutaneous T-cell lymphoma. A clinical, histopathological and immunohistochemical study with particular interest in epithelial growth factor expression. The French Study Group on cutaneous lymphoma [J]. Br J Dermatol. 1999;140(3):421\u20136. https:\/\/doi.org\/10.1046\/j.1365-2133.1999.02703.x.","journal-title":"Br J Dermatol"},{"issue":"6916","key":"9503_CR47","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature01148","volume":"420","author":"S ETIENNE-MANNEVILLE","year":"2002","unstructured":"Etienne-manneville S, Hall A. Rho GTPases in cell biology [J]. Nature. 2002;420(6916):629\u201335. https:\/\/doi.org\/10.1038\/nature01148.","journal-title":"Nature"},{"issue":"4","key":"9503_CR48","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1053\/j.gastro.2021.12.269","volume":"162","author":"S WANG","year":"2022","unstructured":"Wang S, Gao S, Zeng Y, et al. N6-Methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in Colorectal Cancer [J]. Gastroenterology. 2022;162(4):1183\u201396. https:\/\/doi.org\/10.1053\/j.gastro.2021.12.269.","journal-title":"Gastroenterology"},{"issue":"9","key":"9503_CR49","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1158\/0008-5472.CAN-17-2867","volume":"78","author":"YL ZHANG","year":"2018","unstructured":"Zhang YL, Li Q, Yang XM, et al. SPON2 promotes M1-like macrophage recruitment and inhibits Hepatocellular Carcinoma Metastasis by distinct integrin-rho GTPase-Hippo pathways [J]. Cancer Res. 2018;78(9):2305\u201317. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-2867.","journal-title":"Cancer Res"},{"issue":"31","key":"9503_CR50","doi-asserted-by":"publisher","first-page":"eaaz1534","DOI":"10.1126\/sciadv.aaz1534","volume":"6","author":"M PAN","year":"2020","unstructured":"PAN M, CHEW TW, WONG DCP, et al. BNIP-2 retards breast cancer cell migration by coupling microtubule-mediated GEF-H1 and RhoA activation [J]. Sci Adv. 2020;6(31):eaaz1534. https:\/\/doi.org\/10.1126\/sciadv.aaz1534.","journal-title":"Sci Adv"},{"issue":"22","key":"9503_CR51","doi-asserted-by":"publisher","first-page":"4219","DOI":"10.1158\/0008-5472.CAN-22-1170","volume":"82","author":"Y KIM K B, KIM D W, KIM","year":"2022","unstructured":"Kim KB, Kim DW, Kim Y, et al. WNT5A-RHOA signaling is a driver of tumorigenesis and represents a therapeutically actionable vulnerability in small cell lung Cancer [J]. Cancer Res. 2022;82(22):4219\u201333. https:\/\/doi.org\/10.1158\/0008-5472.CAN-22-1170.","journal-title":"Cancer Res"},{"key":"9503_CR52","doi-asserted-by":"publisher","unstructured":"Del pozo MA, Vicente-manzanares M, Tejedor R, et al. Rho GTPases control migration and polarization of adhesion molecules and cytoskeletal ERM components in T lymphocytes [J]. Eur J Immunol. 1999;29(11):3609\u201320. https:\/\/doi.org\/10.1002\/(SICI)1521-4141(199911)29:11%3C3609::AID-IMMU3609%3E3.0.CO;2-S.","DOI":"10.1002\/(SICI)1521-4141(199911)29:11%3C3609::AID-IMMU3609%3E3.0.CO;2-S"},{"issue":"12","key":"9503_CR53","doi-asserted-by":"publisher","first-page":"3403","DOI":"10.1002\/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H","volume":"30","author":"A BORROTO","year":"2000","unstructured":"Borroto A, Gil D, Delgado P, et al. Rho regulates T cell receptor ITAM-induced lymphocyte spreading in an integrin-independent manner [J]. Eur J Immunol. 2000;30(12):3403\u201310. https:\/\/doi.org\/10.1002\/1521-4141(2000012)30:12%3C3403::AID-IMMU3403%3E3.0.CO;2-H.","journal-title":"Eur J Immunol"},{"issue":"9","key":"9503_CR54","doi-asserted-by":"publisher","first-page":"4986","DOI":"10.1128\/MCB.18.9.4986","volume":"18","author":"S CHANG J H, PRATT J C, SAWASDIKOSOL","year":"1998","unstructured":"Chang JH, Pratt JC, Sawasdikosol S, et al. The small GTP-binding protein rho potentiates AP-1 transcription in T cells [J]. Mol Cell Biol. 1998;18(9):4986\u201393. https:\/\/doi.org\/10.1128\/MCB.18.9.4986.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"9503_CR55","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11899-015-0289-7","volume":"10","author":"M SAKATA-YANAGIMOTO","year":"2015","unstructured":"Sakata-yanagimoto M, Chiba S. Molecular pathogenesis of peripheral T cell lymphoma [J]. Curr Hematol Malig Rep. 2015;10(4):429\u201337. https:\/\/doi.org\/10.1007\/s11899-015-0289-7.","journal-title":"Curr Hematol Malig Rep"},{"issue":"1","key":"9503_CR56","doi-asserted-by":"publisher","first-page":"2134536","DOI":"10.1080\/2162402X.2022.2134536","volume":"11","author":"F QUE","year":"2022","unstructured":"Que F, Zhang L, Wang T, et al. RHOA G17V induces T follicular helper cell specification and involves angioimmunoblastic T-cell lymphoma via upregulating the expression of PON2 through an NF-\u03baB-dependent mechanism [J]. Oncoimmunology. 2022;11(1):2134536. https:\/\/doi.org\/10.1080\/2162402X.2022.2134536.","journal-title":"Oncoimmunology"},{"issue":"29","key":"9503_CR57","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1038\/onc.2015.442","volume":"35","author":"M O\u2019HAYRE","year":"2016","unstructured":"O\u2019hayre M, Inoue A, Kufareva I, et al. Inactivating mutations in GNA13 and RHOA in Burkitt\u2019s lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the G\u03b113\/RhoA axis in B cells [J]. Oncogene. 2016;35(29):3771\u201380. https:\/\/doi.org\/10.1038\/onc.2015.442.","journal-title":"Oncogene"},{"issue":"9","key":"9503_CR58","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/pin.12981","volume":"70","author":"H MIYOSHI","year":"2020","unstructured":"Miyoshi H, Sakata-yanagimoto M, Shimono J, et al. RHOA mutation in follicular T-cell lymphoma: clinicopathological analysis of 16 cases [J]. Pathol Int. 2020;70(9):653\u201360. https:\/\/doi.org\/10.1111\/pin.12981.","journal-title":"Pathol Int"},{"issue":"5","key":"9503_CR59","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1182\/blood-2015-06-644948","volume":"127","author":"Y NAGATA","year":"2016","unstructured":"Nagata Y, Kontani K, Enami T, et al. Variegated RHOA mutations in adult T-cell leukemia\/lymphoma [J]. Blood. 2016;127(5):596\u2013604. https:\/\/doi.org\/10.1182\/blood-2015-06-644948.","journal-title":"Blood"},{"issue":"2","key":"9503_CR60","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s43440-020-00068-4","volume":"72","author":"GRABAREKB KRAWCZYK A, STRZALKA-MROZIK B","year":"2020","unstructured":"Krawczyk A, Strzalka-mrozik B Grabarekb, et al. mRNA level of ROCK1, RHOA, and LIMK2 as genes associated with apoptosis in evaluation of effectiveness of adalimumab treatment [J]. Pharmacol Rep. 2020;72(2):389\u201399. https:\/\/doi.org\/10.1007\/s43440-020-00068-4.","journal-title":"Pharmacol Rep"},{"issue":"4","key":"9503_CR61","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1111\/ajd.12801","volume":"59","author":"J LU","year":"2018","unstructured":"Lu J, Yin R, Fu Z, et al. Activation of RhoA, Smad2, c-Src, PKC-\u03b2II\/\u03b4 and JNK in atopic dermatitis [J]. Australas J Dermatol. 2018;59(4):e258\u201361. https:\/\/doi.org\/10.1111\/ajd.12801.","journal-title":"Australas J Dermatol"},{"issue":"6","key":"9503_CR62","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/cdd.2017.56","volume":"24","author":"K KANEMARU","year":"2017","unstructured":"Kanemaru K, Nakamura Y, Totoki K, et al. Phospholipase C\u03b41 regulates p38 MAPK activity and skin barrier integrity [J]. Cell Death Differ. 2017;24(6):1079\u201390. https:\/\/doi.org\/10.1038\/cdd.2017.56.","journal-title":"Cell Death Differ"},{"issue":"2","key":"9503_CR63","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/bjd.21063","volume":"187","author":"J DI RAIMONDO C, RUBIO-GONZALEZ B, PA","year":"2022","unstructured":"Di raimondo C, Rubio-gonzalez B, Palmer J, et al. Expression of immune checkpoint molecules programmed death protein 1, programmed death-ligand 1 and inducible T-cell co-stimulator in mycosis fungoides and S\u00e9zary syndrome: association with disease stage and clinical outcome [J]. Br J Dermatol. 2022;187(2):234\u201343. https:\/\/doi.org\/10.1111\/bjd.21063.","journal-title":"Br J Dermatol"},{"issue":"3","key":"9503_CR64","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1247\/csf.26.179","volume":"26","author":"MA GHERT","year":"2001","unstructured":"Ghert ma, QI WN, ERICKSON HP, et al. Tenascin-C splice variant adhesive\/anti-adhesive effects on chondrosarcoma cell attachment to fibronectin [J]. Cell Struct Funct. 2001;26(3):179\u201387. https:\/\/doi.org\/10.1247\/csf.26.179.","journal-title":"Cell Struct Funct"},{"issue":"11","key":"9503_CR65","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.4049\/jimmunol.167.11.6431","volume":"167","author":"VALMORID PUENTE NAVAZO MD","year":"2001","unstructured":"Puente navazo MD, Valmori D, R\u00fcegg C. The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production [J]. J Immunol. 2001;167(11):6431\u201340. https:\/\/doi.org\/10.4049\/jimmunol.167.11.6431.","journal-title":"J Immunol"},{"issue":"11","key":"9503_CR66","doi-asserted-by":"publisher","first-page":"9766","DOI":"10.18632\/oncotarget.23919","volume":"9","author":"G GRITTI","year":"2018","unstructured":"Gritti G, Gianatti A, Petronzelli F, et al. Evaluation of tenascin-C by tenatumomab in T-cell non-hodgkin lymphomas identifies a new target for radioimmunotherapy[J]. Oncotarget. 2018;9(11):9766\u201375. https:\/\/doi.org\/10.18632\/oncotarget.23919.","journal-title":"Oncotarget"}],"container-title":["Clinical Proteomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-024-09503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12014-024-09503-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12014-024-09503-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,13]],"date-time":"2024-08-13T15:07:14Z","timestamp":1723561634000},"score":1,"resource":{"primary":{"URL":"https:\/\/clinicalproteomicsjournal.biomedcentral.com\/articles\/10.1186\/s12014-024-09503-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,13]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["9503"],"URL":"https:\/\/doi.org\/10.1186\/s12014-024-09503-7","relation":{},"ISSN":["1542-6416","1559-0275"],"issn-type":[{"type":"print","value":"1542-6416"},{"type":"electronic","value":"1559-0275"}],"subject":[],"published":{"date-parts":[[2024,8,13]]},"assertion":[{"value":"18 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences (approval nos. I-22PJ131). All methods were performed in accordance with the guidelines of the Institutional Review Board of Peking Union Medical College Hospital and the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients involved in this study have given their consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}